nodes	percent_of_prediction	percent_of_DWPC	metapath
Apixaban—ABCG2—Nelfinavir—acquired immunodeficiency syndrome	0.0295	0.0358	CbGbCtD
Apixaban—ABCG2—Ritonavir—acquired immunodeficiency syndrome	0.0267	0.0324	CbGbCtD
Apixaban—ABCG2—Saquinavir—acquired immunodeficiency syndrome	0.0267	0.0324	CbGbCtD
Apixaban—ABCG2—Zidovudine—acquired immunodeficiency syndrome	0.0256	0.031	CbGbCtD
Apixaban—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.0216	0.0262	CbGbCtD
Apixaban—ABCG2—Lamivudine—acquired immunodeficiency syndrome	0.0198	0.024	CbGbCtD
Apixaban—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.0195	0.0237	CbGbCtD
Apixaban—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.0195	0.0237	CbGbCtD
Apixaban—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.0188	0.0228	CbGbCtD
Apixaban—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.0188	0.0228	CbGbCtD
Apixaban—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.0185	0.0224	CbGbCtD
Apixaban—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.0174	0.0211	CbGbCtD
Apixaban—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0171	0.0207	CbGbCtD
Apixaban—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.0168	0.0204	CbGbCtD
Apixaban—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.0163	0.0198	CbGbCtD
Apixaban—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0161	0.0195	CbGbCtD
Apixaban—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0161	0.0195	CbGbCtD
Apixaban—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.0157	0.0191	CbGbCtD
Apixaban—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.0157	0.0191	CbGbCtD
Apixaban—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0154	0.0187	CbGbCtD
Apixaban—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.0148	0.0179	CbGbCtD
Apixaban—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.0148	0.0179	CbGbCtD
Apixaban—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0145	0.0176	CbGbCtD
Apixaban—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0145	0.0175	CbGbCtD
Apixaban—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0145	0.0175	CbGbCtD
Apixaban—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.0142	0.0172	CbGbCtD
Apixaban—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.0142	0.0172	CbGbCtD
Apixaban—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.014	0.017	CbGbCtD
Apixaban—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.0136	0.0165	CbGbCtD
Apixaban—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.0136	0.0165	CbGbCtD
Apixaban—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.0132	0.016	CbGbCtD
Apixaban—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0131	0.0159	CbGbCtD
Apixaban—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0131	0.0159	CbGbCtD
Apixaban—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0127	0.0154	CbGbCtD
Apixaban—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0122	0.0148	CbGbCtD
Apixaban—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.0119	0.0145	CbGbCtD
Apixaban—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.0119	0.0145	CbGbCtD
Apixaban—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.0114	0.0139	CbGbCtD
Apixaban—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0113	0.0137	CbGbCtD
Apixaban—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.011	0.0133	CbGbCtD
Apixaban—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.011	0.0133	CbGbCtD
Apixaban—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.011	0.0133	CbGbCtD
Apixaban—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.0106	0.0129	CbGbCtD
Apixaban—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.00991	0.012	CbGbCtD
Apixaban—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.00991	0.012	CbGbCtD
Apixaban—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.00962	0.0117	CbGbCtD
Apixaban—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.00962	0.0117	CbGbCtD
Apixaban—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.00951	0.0115	CbGbCtD
Apixaban—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.00922	0.0112	CbGbCtD
Apixaban—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00895	0.0109	CbGbCtD
Apixaban—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00841	0.0102	CbGbCtD
Apixaban—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00841	0.0102	CbGbCtD
Apixaban—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00761	0.00923	CbGbCtD
Apixaban—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00761	0.00923	CbGbCtD
Apixaban—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00714	0.00866	CbGbCtD
Apixaban—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00657	0.00796	CbGbCtD
Apixaban—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00637	0.00773	CbGbCtD
Apixaban—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00576	0.00699	CbGbCtD
Apixaban—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00576	0.00699	CbGbCtD
Apixaban—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00553	0.0067	CbGbCtD
Apixaban—F10—blood plasma—acquired immunodeficiency syndrome	0.00384	0.108	CbGeAlD
Apixaban—CYP2J2—skin of body—acquired immunodeficiency syndrome	0.00151	0.0424	CbGeAlD
Apixaban—F10—blood—acquired immunodeficiency syndrome	0.00141	0.0394	CbGeAlD
Apixaban—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.0014	0.0394	CbGeAlD
Apixaban—F10—vagina—acquired immunodeficiency syndrome	0.0013	0.0365	CbGeAlD
Apixaban—F10—lung—acquired immunodeficiency syndrome	0.00123	0.0345	CbGeAlD
Apixaban—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.00123	0.0344	CbGeAlD
Apixaban—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.00115	0.0322	CbGeAlD
Apixaban—CYP2J2—spinal cord—acquired immunodeficiency syndrome	0.00111	0.0311	CbGeAlD
Apixaban—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.00111	0.031	CbGeAlD
Apixaban—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.00109	0.0305	CbGeAlD
Apixaban—CYP2J2—vagina—acquired immunodeficiency syndrome	0.00107	0.0299	CbGeAlD
Apixaban—CYP2J2—lung—acquired immunodeficiency syndrome	0.00101	0.0283	CbGeAlD
Apixaban—CYP2J2—nervous system—acquired immunodeficiency syndrome	0.000935	0.0262	CbGeAlD
Apixaban—CYP2J2—central nervous system—acquired immunodeficiency syndrome	0.0009	0.0252	CbGeAlD
Apixaban—F10—lymph node—acquired immunodeficiency syndrome	0.000843	0.0236	CbGeAlD
Apixaban—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000831	0.0233	CbGeAlD
Apixaban—CYP2J2—brain—acquired immunodeficiency syndrome	0.000715	0.02	CbGeAlD
Apixaban—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000588	0.0165	CbGeAlD
Apixaban—Hepatobiliary disease—Nevirapine—acquired immunodeficiency syndrome	0.000559	0.004	CcSEcCtD
Apixaban—Diabetes mellitus—Saquinavir—acquired immunodeficiency syndrome	0.000554	0.00396	CcSEcCtD
Apixaban—Blood alkaline phosphatase increased—Saquinavir—acquired immunodeficiency syndrome	0.000554	0.00396	CcSEcCtD
Apixaban—Haematuria—Stavudine—acquired immunodeficiency syndrome	0.000545	0.00389	CcSEcCtD
Apixaban—Hepatobiliary disease—Nelfinavir—acquired immunodeficiency syndrome	0.000542	0.00387	CcSEcCtD
Apixaban—Gastrointestinal haemorrhage—Delavirdine—acquired immunodeficiency syndrome	0.000542	0.00387	CcSEcCtD
Apixaban—Epistaxis—Nelfinavir—acquired immunodeficiency syndrome	0.00054	0.00386	CcSEcCtD
Apixaban—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.00054	0.0151	CbGeAlD
Apixaban—Hepatobiliary disease—Stavudine—acquired immunodeficiency syndrome	0.00054	0.00386	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Indinavir—acquired immunodeficiency syndrome	0.000539	0.00386	CcSEcCtD
Apixaban—Hepatobiliary disease—Abacavir—acquired immunodeficiency syndrome	0.000532	0.0038	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Indinavir—acquired immunodeficiency syndrome	0.000528	0.00378	CcSEcCtD
Apixaban—Connective tissue disorder—Nevirapine—acquired immunodeficiency syndrome	0.000522	0.00373	CcSEcCtD
Apixaban—Haemoglobin—Nelfinavir—acquired immunodeficiency syndrome	0.000517	0.0037	CcSEcCtD
Apixaban—CYP2C19—blood—acquired immunodeficiency syndrome	0.000515	0.0144	CbGeAlD
Apixaban—Haemorrhage—Nelfinavir—acquired immunodeficiency syndrome	0.000514	0.00368	CcSEcCtD
Apixaban—Breast disorder—Efavirenz—acquired immunodeficiency syndrome	0.000511	0.00366	CcSEcCtD
Apixaban—Connective tissue disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000505	0.00361	CcSEcCtD
Apixaban—Connective tissue disorder—Stavudine—acquired immunodeficiency syndrome	0.000504	0.0036	CcSEcCtD
Apixaban—Gastrointestinal haemorrhage—Ritonavir—acquired immunodeficiency syndrome	0.000501	0.00358	CcSEcCtD
Apixaban—Connective tissue disorder—Abacavir—acquired immunodeficiency syndrome	0.000496	0.00355	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Delavirdine—acquired immunodeficiency syndrome	0.000488	0.00349	CcSEcCtD
Apixaban—Gastrointestinal haemorrhage—Saquinavir—acquired immunodeficiency syndrome	0.000482	0.00345	CcSEcCtD
Apixaban—Eye disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000481	0.00344	CcSEcCtD
Apixaban—Immune system disorder—Nevirapine—acquired immunodeficiency syndrome	0.00048	0.00343	CcSEcCtD
Apixaban—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000477	0.0134	CbGeAlD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Amprenavir—acquired immunodeficiency syndrome	0.000477	0.00341	CcSEcCtD
Apixaban—Anaemia—Didanosine—acquired immunodeficiency syndrome	0.000475	0.0034	CcSEcCtD
Apixaban—Haematuria—Zidovudine—acquired immunodeficiency syndrome	0.000473	0.00338	CcSEcCtD
Apixaban—Hepatobiliary disease—Zidovudine—acquired immunodeficiency syndrome	0.000469	0.00336	CcSEcCtD
Apixaban—Epistaxis—Zidovudine—acquired immunodeficiency syndrome	0.000468	0.00335	CcSEcCtD
Apixaban—Angiopathy—Nelfinavir—acquired immunodeficiency syndrome	0.000467	0.00334	CcSEcCtD
Apixaban—Immune system disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000464	0.00332	CcSEcCtD
Apixaban—Liver function test abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000462	0.00331	CcSEcCtD
Apixaban—Immune system disorder—Abacavir—acquired immunodeficiency syndrome	0.000456	0.00326	CcSEcCtD
Apixaban—Breast disorder—Ritonavir—acquired immunodeficiency syndrome	0.000453	0.00324	CcSEcCtD
Apixaban—Nervous system disorder—Amprenavir—acquired immunodeficiency syndrome	0.000451	0.00323	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Ritonavir—acquired immunodeficiency syndrome	0.000451	0.00322	CcSEcCtD
Apixaban—CYP2C8—blood—acquired immunodeficiency syndrome	0.000449	0.0126	CbGeAlD
Apixaban—Skin disorder—Amprenavir—acquired immunodeficiency syndrome	0.000447	0.0032	CcSEcCtD
Apixaban—Liver function test abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000445	0.00318	CcSEcCtD
Apixaban—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000441	0.0124	CbGeAlD
Apixaban—Haematuria—Indinavir—acquired immunodeficiency syndrome	0.00044	0.00315	CcSEcCtD
Apixaban—Urinary tract disorder—Zidovudine—acquired immunodeficiency syndrome	0.00044	0.00315	CcSEcCtD
Apixaban—Connective tissue disorder—Zidovudine—acquired immunodeficiency syndrome	0.000438	0.00313	CcSEcCtD
Apixaban—Urethral disorder—Zidovudine—acquired immunodeficiency syndrome	0.000437	0.00312	CcSEcCtD
Apixaban—ABCG2—blood—acquired immunodeficiency syndrome	0.000437	0.0122	CbGeAlD
Apixaban—Hepatobiliary disease—Indinavir—acquired immunodeficiency syndrome	0.000437	0.00312	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Saquinavir—acquired immunodeficiency syndrome	0.000434	0.0031	CcSEcCtD
Apixaban—Anaemia—Nevirapine—acquired immunodeficiency syndrome	0.000427	0.00305	CcSEcCtD
Apixaban—CYP3A5—digestive system—acquired immunodeficiency syndrome	0.000426	0.0119	CbGeAlD
Apixaban—Alanine aminotransferase increased—Saquinavir—acquired immunodeficiency syndrome	0.000425	0.00304	CcSEcCtD
Apixaban—Liver function test abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000425	0.00303	CcSEcCtD
Apixaban—ABCG2—bone marrow—acquired immunodeficiency syndrome	0.000423	0.0118	CbGeAlD
Apixaban—ABCG2—spinal cord—acquired immunodeficiency syndrome	0.000421	0.0118	CbGeAlD
Apixaban—CYP1A2—blood—acquired immunodeficiency syndrome	0.00042	0.0118	CbGeAlD
Apixaban—Anaphylactic shock—Didanosine—acquired immunodeficiency syndrome	0.00042	0.003	CcSEcCtD
Apixaban—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000419	0.0117	CbGeAlD
Apixaban—Haemoglobin—Indinavir—acquired immunodeficiency syndrome	0.000417	0.00298	CcSEcCtD
Apixaban—CYP2C8—vagina—acquired immunodeficiency syndrome	0.000416	0.0117	CbGeAlD
Apixaban—Haematuria—Efavirenz—acquired immunodeficiency syndrome	0.000416	0.00297	CcSEcCtD
Apixaban—Haemorrhage—Indinavir—acquired immunodeficiency syndrome	0.000414	0.00296	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Lamivudine—acquired immunodeficiency syndrome	0.000414	0.00296	CcSEcCtD
Apixaban—Anaemia—Nelfinavir—acquired immunodeficiency syndrome	0.000414	0.00296	CcSEcCtD
Apixaban—Hepatobiliary disease—Efavirenz—acquired immunodeficiency syndrome	0.000412	0.00295	CcSEcCtD
Apixaban—Anaemia—Stavudine—acquired immunodeficiency syndrome	0.000412	0.00295	CcSEcCtD
Apixaban—Thrombocytopenia—Didanosine—acquired immunodeficiency syndrome	0.000411	0.00294	CcSEcCtD
Apixaban—Urinary tract disorder—Indinavir—acquired immunodeficiency syndrome	0.000409	0.00293	CcSEcCtD
Apixaban—Connective tissue disorder—Indinavir—acquired immunodeficiency syndrome	0.000407	0.00291	CcSEcCtD
Apixaban—Anaemia—Abacavir—acquired immunodeficiency syndrome	0.000406	0.00291	CcSEcCtD
Apixaban—Urethral disorder—Indinavir—acquired immunodeficiency syndrome	0.000406	0.0029	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Lamivudine—acquired immunodeficiency syndrome	0.000406	0.0029	CcSEcCtD
Apixaban—CYP3A5—blood—acquired immunodeficiency syndrome	0.000405	0.0114	CbGeAlD
Apixaban—ABCG2—vagina—acquired immunodeficiency syndrome	0.000405	0.0114	CbGeAlD
Apixaban—Mediastinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000402	0.00287	CcSEcCtD
Apixaban—CYP2C9—blood—acquired immunodeficiency syndrome	0.000399	0.0112	CbGeAlD
Apixaban—Haematuria—Delavirdine—acquired immunodeficiency syndrome	0.000398	0.00284	CcSEcCtD
Apixaban—Gastrointestinal disorder—Amprenavir—acquired immunodeficiency syndrome	0.000397	0.00284	CcSEcCtD
Apixaban—Epistaxis—Delavirdine—acquired immunodeficiency syndrome	0.000394	0.00281	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Nevirapine—acquired immunodeficiency syndrome	0.000391	0.00279	CcSEcCtD
Apixaban—Urinary tract disorder—Efavirenz—acquired immunodeficiency syndrome	0.000387	0.00276	CcSEcCtD
Apixaban—Connective tissue disorder—Efavirenz—acquired immunodeficiency syndrome	0.000385	0.00275	CcSEcCtD
Apixaban—Urethral disorder—Efavirenz—acquired immunodeficiency syndrome	0.000384	0.00274	CcSEcCtD
Apixaban—ABCG2—lung—acquired immunodeficiency syndrome	0.000383	0.0107	CbGeAlD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Nelfinavir—acquired immunodeficiency syndrome	0.000378	0.00271	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Stavudine—acquired immunodeficiency syndrome	0.000377	0.0027	CcSEcCtD
Apixaban—Anaphylactic shock—Nevirapine—acquired immunodeficiency syndrome	0.000377	0.0027	CcSEcCtD
Apixaban—CYP3A5—vagina—acquired immunodeficiency syndrome	0.000376	0.0105	CbGeAlD
Apixaban—Immune system disorder—Indinavir—acquired immunodeficiency syndrome	0.000374	0.00268	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Abacavir—acquired immunodeficiency syndrome	0.000372	0.00266	CcSEcCtD
Apixaban—Nervous system disorder—Nevirapine—acquired immunodeficiency syndrome	0.00037	0.00264	CcSEcCtD
Apixaban—Thrombocytopenia—Nevirapine—acquired immunodeficiency syndrome	0.000369	0.00264	CcSEcCtD
Apixaban—CYP1A2—lung—acquired immunodeficiency syndrome	0.000368	0.0103	CbGeAlD
Apixaban—Haematuria—Ritonavir—acquired immunodeficiency syndrome	0.000368	0.00263	CcSEcCtD
Apixaban—Skin disorder—Nevirapine—acquired immunodeficiency syndrome	0.000366	0.00262	CcSEcCtD
Apixaban—Eye disorder—Efavirenz—acquired immunodeficiency syndrome	0.000366	0.00262	CcSEcCtD
Apixaban—Hepatobiliary disease—Ritonavir—acquired immunodeficiency syndrome	0.000365	0.00261	CcSEcCtD
Apixaban—Epistaxis—Ritonavir—acquired immunodeficiency syndrome	0.000364	0.0026	CcSEcCtD
Apixaban—Anaphylactic shock—Abacavir—acquired immunodeficiency syndrome	0.000359	0.00257	CcSEcCtD
Apixaban—Anaemia—Zidovudine—acquired immunodeficiency syndrome	0.000359	0.00256	CcSEcCtD
Apixaban—Thrombocytopenia—Nelfinavir—acquired immunodeficiency syndrome	0.000358	0.00256	CcSEcCtD
Apixaban—Nervous system disorder—Stavudine—acquired immunodeficiency syndrome	0.000357	0.00255	CcSEcCtD
Apixaban—Thrombocytopenia—Stavudine—acquired immunodeficiency syndrome	0.000357	0.00255	CcSEcCtD
Apixaban—CYP3A5—lung—acquired immunodeficiency syndrome	0.000355	0.00997	CbGeAlD
Apixaban—Angiopathy—Efavirenz—acquired immunodeficiency syndrome	0.000355	0.00254	CcSEcCtD
Apixaban—Skin disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000355	0.00254	CcSEcCtD
Apixaban—Skin disorder—Stavudine—acquired immunodeficiency syndrome	0.000354	0.00253	CcSEcCtD
Apixaban—Immune system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000354	0.00253	CcSEcCtD
Apixaban—Mediastinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000353	0.00252	CcSEcCtD
Apixaban—Nervous system disorder—Abacavir—acquired immunodeficiency syndrome	0.000352	0.00252	CcSEcCtD
Apixaban—Thrombocytopenia—Abacavir—acquired immunodeficiency syndrome	0.000351	0.00251	CcSEcCtD
Apixaban—Hepatobiliary disease—Saquinavir—acquired immunodeficiency syndrome	0.000351	0.00251	CcSEcCtD
Apixaban—Epistaxis—Saquinavir—acquired immunodeficiency syndrome	0.00035	0.0025	CcSEcCtD
Apixaban—Skin disorder—Abacavir—acquired immunodeficiency syndrome	0.000349	0.00249	CcSEcCtD
Apixaban—Haemoglobin—Ritonavir—acquired immunodeficiency syndrome	0.000348	0.00249	CcSEcCtD
Apixaban—Syncope—Zidovudine—acquired immunodeficiency syndrome	0.000348	0.00249	CcSEcCtD
Apixaban—Haemorrhage—Ritonavir—acquired immunodeficiency syndrome	0.000346	0.00248	CcSEcCtD
Apixaban—Urinary tract disorder—Ritonavir—acquired immunodeficiency syndrome	0.000342	0.00245	CcSEcCtD
Apixaban—Loss of consciousness—Zidovudine—acquired immunodeficiency syndrome	0.000341	0.00244	CcSEcCtD
Apixaban—Connective tissue disorder—Ritonavir—acquired immunodeficiency syndrome	0.00034	0.00243	CcSEcCtD
Apixaban—Urethral disorder—Ritonavir—acquired immunodeficiency syndrome	0.00034	0.00243	CcSEcCtD
Apixaban—Hypotension—Abacavir—acquired immunodeficiency syndrome	0.000335	0.0024	CcSEcCtD
Apixaban—Haemoglobin—Saquinavir—acquired immunodeficiency syndrome	0.000335	0.0024	CcSEcCtD
Apixaban—Hepatobiliary disease—Lamivudine—acquired immunodeficiency syndrome	0.000335	0.0024	CcSEcCtD
Apixaban—Epistaxis—Lamivudine—acquired immunodeficiency syndrome	0.000334	0.00239	CcSEcCtD
Apixaban—Haemorrhage—Saquinavir—acquired immunodeficiency syndrome	0.000333	0.00238	CcSEcCtD
Apixaban—Anaemia—Indinavir—acquired immunodeficiency syndrome	0.000333	0.00238	CcSEcCtD
Apixaban—Urinary tract disorder—Saquinavir—acquired immunodeficiency syndrome	0.000329	0.00235	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Zidovudine—acquired immunodeficiency syndrome	0.000328	0.00234	CcSEcCtD
Apixaban—Connective tissue disorder—Saquinavir—acquired immunodeficiency syndrome	0.000328	0.00234	CcSEcCtD
Apixaban—Urethral disorder—Saquinavir—acquired immunodeficiency syndrome	0.000327	0.00234	CcSEcCtD
Apixaban—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.000326	0.00233	CcSEcCtD
Apixaban—Eye disorder—Ritonavir—acquired immunodeficiency syndrome	0.000324	0.00231	CcSEcCtD
Apixaban—Syncope—Indinavir—acquired immunodeficiency syndrome	0.000324	0.00231	CcSEcCtD
Apixaban—ABCB1—retina—acquired immunodeficiency syndrome	0.000322	0.00903	CbGeAlD
Apixaban—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000319	0.00895	CbGeAlD
Apixaban—Loss of consciousness—Indinavir—acquired immunodeficiency syndrome	0.000317	0.00227	CcSEcCtD
Apixaban—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.000317	0.00226	CcSEcCtD
Apixaban—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000315	0.00225	CcSEcCtD
Apixaban—Anaemia—Efavirenz—acquired immunodeficiency syndrome	0.000315	0.00225	CcSEcCtD
Apixaban—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.000314	0.00225	CcSEcCtD
Apixaban—Angiopathy—Ritonavir—acquired immunodeficiency syndrome	0.000314	0.00225	CcSEcCtD
Apixaban—Immune system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000313	0.00224	CcSEcCtD
Apixaban—Connective tissue disorder—Lamivudine—acquired immunodeficiency syndrome	0.000313	0.00223	CcSEcCtD
Apixaban—Mediastinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000312	0.00223	CcSEcCtD
Apixaban—Eye disorder—Saquinavir—acquired immunodeficiency syndrome	0.000312	0.00223	CcSEcCtD
Apixaban—Shock—Zidovudine—acquired immunodeficiency syndrome	0.000311	0.00223	CcSEcCtD
Apixaban—Nervous system disorder—Zidovudine—acquired immunodeficiency syndrome	0.00031	0.00222	CcSEcCtD
Apixaban—Thrombocytopenia—Zidovudine—acquired immunodeficiency syndrome	0.00031	0.00222	CcSEcCtD
Apixaban—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.00031	0.00221	CcSEcCtD
Apixaban—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.000309	0.00221	CcSEcCtD
Apixaban—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	0.000307	0.0022	CcSEcCtD
Apixaban—Syncope—Efavirenz—acquired immunodeficiency syndrome	0.000306	0.00219	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Indinavir—acquired immunodeficiency syndrome	0.000305	0.00218	CcSEcCtD
Apixaban—CYP3A4—blood—acquired immunodeficiency syndrome	0.000304	0.00853	CbGeAlD
Apixaban—Angiopathy—Saquinavir—acquired immunodeficiency syndrome	0.000303	0.00216	CcSEcCtD
Apixaban—Anaemia—Delavirdine—acquired immunodeficiency syndrome	0.000301	0.00215	CcSEcCtD
Apixaban—Immune system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000301	0.00215	CcSEcCtD
Apixaban—Mediastinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000301	0.00215	CcSEcCtD
Apixaban—Loss of consciousness—Efavirenz—acquired immunodeficiency syndrome	0.0003	0.00214	CcSEcCtD
Apixaban—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.000294	0.0021	CcSEcCtD
Apixaban—Syncope—Delavirdine—acquired immunodeficiency syndrome	0.000292	0.00209	CcSEcCtD
Apixaban—Rash—Amprenavir—acquired immunodeficiency syndrome	0.00029	0.00207	CcSEcCtD
Apixaban—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.00029	0.00207	CcSEcCtD
Apixaban—Shock—Indinavir—acquired immunodeficiency syndrome	0.00029	0.00207	CcSEcCtD
Apixaban—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.000289	0.00206	CcSEcCtD
Apixaban—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.000288	0.00206	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.000288	0.00206	CcSEcCtD
Apixaban—Immune system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000287	0.00205	CcSEcCtD
Apixaban—Mediastinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000287	0.00205	CcSEcCtD
Apixaban—Loss of consciousness—Delavirdine—acquired immunodeficiency syndrome	0.000287	0.00205	CcSEcCtD
Apixaban—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.000286	0.00204	CcSEcCtD
Apixaban—Anaemia—Ritonavir—acquired immunodeficiency syndrome	0.000279	0.00199	CcSEcCtD
Apixaban—CYP2C8—brain—acquired immunodeficiency syndrome	0.000279	0.00782	CbGeAlD
Apixaban—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000278	0.00199	CcSEcCtD
Apixaban—Shock—Efavirenz—acquired immunodeficiency syndrome	0.000274	0.00196	CcSEcCtD
Apixaban—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000273	0.00195	CcSEcCtD
Apixaban—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000273	0.00195	CcSEcCtD
Apixaban—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000273	0.00195	CcSEcCtD
Apixaban—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000272	0.00195	CcSEcCtD
Apixaban—ABCG2—brain—acquired immunodeficiency syndrome	0.000271	0.0076	CbGeAlD
Apixaban—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.00027	0.00193	CcSEcCtD
Apixaban—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.00027	0.00193	CcSEcCtD
Apixaban—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000269	0.00192	CcSEcCtD
Apixaban—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000268	0.00192	CcSEcCtD
Apixaban—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.000268	0.00192	CcSEcCtD
Apixaban—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000265	0.00189	CcSEcCtD
Apixaban—Rash—Didanosine—acquired immunodeficiency syndrome	0.000265	0.00189	CcSEcCtD
Apixaban—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000264	0.00189	CcSEcCtD
Apixaban—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000264	0.00189	CcSEcCtD
Apixaban—ABCG2—lymph node—acquired immunodeficiency syndrome	0.000262	0.00734	CbGeAlD
Apixaban—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000262	0.00187	CcSEcCtD
Apixaban—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000261	0.00186	CcSEcCtD
Apixaban—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.00026	0.00186	CcSEcCtD
Apixaban—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000259	0.00185	CcSEcCtD
Apixaban—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000256	0.00183	CcSEcCtD
Apixaban—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000255	0.00182	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000255	0.00182	CcSEcCtD
Apixaban—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000254	0.00182	CcSEcCtD
Apixaban—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000249	0.00178	CcSEcCtD
Apixaban—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000249	0.00178	CcSEcCtD
Apixaban—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000248	0.00178	CcSEcCtD
Apixaban—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000247	0.00693	CbGeAlD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000245	0.00175	CcSEcCtD
Apixaban—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000243	0.00174	CcSEcCtD
Apixaban—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000242	0.00173	CcSEcCtD
Apixaban—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000242	0.00173	CcSEcCtD
Apixaban—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000241	0.00173	CcSEcCtD
Apixaban—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000241	0.00172	CcSEcCtD
Apixaban—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000241	0.00172	CcSEcCtD
Apixaban—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.00024	0.00172	CcSEcCtD
Apixaban—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000239	0.00171	CcSEcCtD
Apixaban—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000238	0.0017	CcSEcCtD
Apixaban—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000238	0.00667	CbGeAlD
Apixaban—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000238	0.0017	CcSEcCtD
Apixaban—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000237	0.0017	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000234	0.00167	CcSEcCtD
Apixaban—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000233	0.00167	CcSEcCtD
Apixaban—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000232	0.00166	CcSEcCtD
Apixaban—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000232	0.00166	CcSEcCtD
Apixaban—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00023	0.00165	CcSEcCtD
Apixaban—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00023	0.00165	CcSEcCtD
Apixaban—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.00023	0.00165	CcSEcCtD
Apixaban—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.00023	0.00164	CcSEcCtD
Apixaban—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.00023	0.00164	CcSEcCtD
Apixaban—Rash—Stavudine—acquired immunodeficiency syndrome	0.00023	0.00164	CcSEcCtD
Apixaban—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000229	0.00164	CcSEcCtD
Apixaban—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000229	0.00642	CbGeAlD
Apixaban—Rash—Abacavir—acquired immunodeficiency syndrome	0.000226	0.00162	CcSEcCtD
Apixaban—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000226	0.00634	CbGeAlD
Apixaban—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000226	0.00162	CcSEcCtD
Apixaban—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000226	0.00162	CcSEcCtD
Apixaban—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000224	0.0016	CcSEcCtD
Apixaban—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000222	0.00159	CcSEcCtD
Apixaban—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000222	0.00158	CcSEcCtD
Apixaban—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000221	0.00158	CcSEcCtD
Apixaban—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000221	0.00158	CcSEcCtD
Apixaban—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.00022	0.00157	CcSEcCtD
Apixaban—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000217	0.00155	CcSEcCtD
Apixaban—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000217	0.00155	CcSEcCtD
Apixaban—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000216	0.00155	CcSEcCtD
Apixaban—ABCB1—blood—acquired immunodeficiency syndrome	0.000215	0.00604	CbGeAlD
Apixaban—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000213	0.00152	CcSEcCtD
Apixaban—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000212	0.00152	CcSEcCtD
Apixaban—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000211	0.00151	CcSEcCtD
Apixaban—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000209	0.0015	CcSEcCtD
Apixaban—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000208	0.00584	CbGeAlD
Apixaban—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000207	0.00582	CbGeAlD
Apixaban—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000205	0.00147	CcSEcCtD
Apixaban—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000205	0.00146	CcSEcCtD
Apixaban—ABCB1—vagina—acquired immunodeficiency syndrome	0.0002	0.0056	CbGeAlD
Apixaban—Rash—Zidovudine—acquired immunodeficiency syndrome	0.0002	0.00143	CcSEcCtD
Apixaban—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000199	0.00143	CcSEcCtD
Apixaban—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000196	0.0014	CcSEcCtD
Apixaban—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000195	0.00139	CcSEcCtD
Apixaban—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000195	0.00139	CcSEcCtD
Apixaban—ABCB1—lung—acquired immunodeficiency syndrome	0.000189	0.00529	CbGeAlD
Apixaban—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000188	0.00134	CcSEcCtD
Apixaban—Rash—Indinavir—acquired immunodeficiency syndrome	0.000186	0.00133	CcSEcCtD
Apixaban—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000185	0.00133	CcSEcCtD
Apixaban—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000184	0.00132	CcSEcCtD
Apixaban—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000181	0.0013	CcSEcCtD
Apixaban—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000176	0.00126	CcSEcCtD
Apixaban—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000175	0.00125	CcSEcCtD
Apixaban—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000175	0.00125	CcSEcCtD
Apixaban—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000175	0.00125	CcSEcCtD
Apixaban—ABCB1—nervous system—acquired immunodeficiency syndrome	0.000175	0.0049	CbGeAlD
Apixaban—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000175	0.00125	CcSEcCtD
Apixaban—ABCB1—central nervous system—acquired immunodeficiency syndrome	0.000168	0.00472	CbGeAlD
Apixaban—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000168	0.0012	CcSEcCtD
Apixaban—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000168	0.0012	CcSEcCtD
Apixaban—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000167	0.00119	CcSEcCtD
Apixaban—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000165	0.00118	CcSEcCtD
Apixaban—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000163	0.00116	CcSEcCtD
Apixaban—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000158	0.00113	CcSEcCtD
Apixaban—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000157	0.00112	CcSEcCtD
Apixaban—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000155	0.00111	CcSEcCtD
Apixaban—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000155	0.00111	CcSEcCtD
Apixaban—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000149	0.00107	CcSEcCtD
Apixaban—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000149	0.00107	CcSEcCtD
Apixaban—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000149	0.00107	CcSEcCtD
Apixaban—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000146	0.00105	CcSEcCtD
Apixaban—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000142	0.00102	CcSEcCtD
Apixaban—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000142	0.00102	CcSEcCtD
Apixaban—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000141	0.00101	CcSEcCtD
Apixaban—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000134	0.00096	CcSEcCtD
Apixaban—ABCB1—brain—acquired immunodeficiency syndrome	0.000134	0.00375	CbGeAlD
Apixaban—ABCB1—lymph node—acquired immunodeficiency syndrome	0.000129	0.00362	CbGeAlD
